Cargando…

Pyrazolo Derivatives as Potent Adenosine Receptor Antagonists: An Overview on the Structure-Activity Relationships

In the past few decades, medicinal chemistry research towards potent and selective antagonists of human adenosine receptors (namely, A(1), A(2A), A(2B), and A(3)) has been evolving rapidly. These antagonists are deemed therapeutically beneficial in several pathological conditions including neurologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheong, Siew Lee, Venkatesan, Gopalakrishnan, Paira, Priyankar, Jothibasu, Ramasamy, Mandel, Alexander Laurence, Federico, Stephanie, Spalluto, Giampiero, Pastorin, Giorgia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411897/ https://www.ncbi.nlm.nih.gov/pubmed/25954519 http://dx.doi.org/10.1155/2011/480652

Ejemplares similares

Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes
por: Bolcato, Chiara, et al.
Publicado: (2007)

Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A(2A) and dopamine D(2) receptors for Parkinson's disease treatment
por: Shao, Yi-Ming, et al.
Publicado: (2018)

Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure–activity profile
por: Cacciari, Barbara, et al.
Publicado: (2006)

Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors
por: Salmaso, Veronica, et al.
Publicado: (2023)

Chemical Probes for the Adenosine Receptors
por: Federico, Stephanie, et al.
Publicado: (2019)

Design, Synthesis and Evaluation of New Indolylpyrimidylpiperazines for Gastrointestinal Cancer Therapy
por: Tan, Aaron, et al.
Publicado: (2019)

The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives
por: Federico, Stephanie, et al.
Publicado: (2015)

4-Hydrazino-1-methylpyrazolo[3,4-d]pyrimidine
por: Dolzhenko, Anton V., et al.
Publicado: (2009)

Discovery of benzothiazolylquinoline conjugates as novel human A(3) receptor antagonists: biological evaluations and molecular docking studies
por: Sarkar, Bidisha, et al.
Publicado: (2018)

New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile
por: Lambertucci, Catia, et al.
Publicado: (2007)

Different routes for the construction of biologically active diversely functionalized bicyclo[3.3.1]nonanes: an exploration of new perspectives for anticancer chemotherapeutics
por: Roy, Nilmadhab, et al.
Publicado: (2023)

CuAAC “Click”-Derived Luminescent 2-(2-(4-(4-(Pyridin-2-yl)-1H-1,2,3-triazol-1-yl)butoxy)phenyl)benzo[d]thiazole-Based Ru(II)/Ir(III)/Re(I) Complexes as Anticancer Agents
por: Thilak Babu, Lavanya, et al.
Publicado: (2023)

Discovery of a High Affinity Adenosine A(1)/A(3) Receptor Antagonist with a Novel 7-Amino-pyrazolo[3,4-d]pyridazine Scaffold
por: Suchankova, Anna, et al.
Publicado: (2022)

8-Methyl-2-[4-(trifluoromethyl)phenyl]-8H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine methanol disolvate
por: Dolzhenko, Anton V., et al.
Publicado: (2010)

Luminescent bis(benzo[d]thiazolyl)quinoxaline: facile synthesis, nucleic acid and protein BSA interaction, live-cell imaging, biopharmaceutical research and cancer theranostic application
por: Babu, Lavanya Thilak, et al.
Publicado: (2019)

Exploring the Effect of Halogenation in a Series of Potent and Selective A(2B) Adenosine Receptor Antagonists
por: Prieto-Díaz, Rubén, et al.
Publicado: (2022)

Ru(ii)arene(N^N bpy/phen)-based RAPTA complexes for in vitro anti-tumour activity in human glioblastoma cancer cell lines and in vivo toxicity studies in a zebrafish model
por: P. K., Anuja, et al.
Publicado: (2022)

Target-specific mononuclear and binuclear rhenium(i) tricarbonyl complexes as upcoming anticancer drugs
por: Sharma S., Ajay, et al.
Publicado: (2022)

Potent Alkaline Phosphatase Inhibitors, Pyrazolo-Oxothiazolidines: Synthesis, Biological Evaluation, Molecular Docking, and Kinetic Studies
por: Hosseini Nasab, Narges, et al.
Publicado: (2022)

Bitopic fluorescent antagonists of the A(2A) adenosine receptor based on pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine functionalized congeners
por: Duroux, Romain, et al.
Publicado: (2017)

Water-mediated green synthesis of PbS quantum dot and its glutathione and biotin conjugates for non-invasive live cell imaging
por: Vijaya Bharathi, M., et al.
Publicado: (2018)

Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist
por: Bai, Yu, et al.
Publicado: (2022)

Discovery of Novel Dual Adenosine A(2A) and A(1) Receptor Antagonists with 1H-Pyrazolo[3,4-d]pyrimidin-6-amine Core Scaffold as Anti-Parkinson’s Disease Agents
por: Jung, Juyoung, et al.
Publicado: (2022)

Effect of Adenosine Receptor Antagonists on Adenosine-Pretreated PC12 Cells Exposed to Paraquat
por: Shang, Liangcheng, et al.
Publicado: (2022)

Identification of 1H-pyrazolo[3,4-b]pyridine derivatives as potent ALK-L1196M inhibitors
por: Nam, Yunju, et al.
Publicado: (2019)

Irreversible Antagonists for the Adenosine A(2B) Receptor †
por: Temirak, Ahmed, et al.
Publicado: (2022)

Mitochondria-targeted half-sandwich iridium(iii)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468
por: Mondal, Ashaparna, et al.
Publicado: (2022)

Non-Nucleoside Agonists of the Adenosine Receptors: An Overview
por: Dal Ben, Diego, et al.
Publicado: (2019)

Discovery of a potent protein kinase D inhibitor: insights in the binding mode of pyrazolo[3,4-d]pyrimidine analogues
por: Verschueren, Klaas, et al.
Publicado: (2017)

Pharmacological characterisation of novel adenosine A(3) receptor antagonists
por: Barkan, Kerry, et al.
Publicado: (2020)

Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity
por: Koch, Pierre, et al.
Publicado: (2018)

Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase
por: Crespo, Roberto A., et al.
Publicado: (2019)

Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
por: Yang, Zijian, et al.
Publicado: (2015)

Androgen Receptor Antagonists and Anti-Prostate Cancer Activities of Some Newly Synthesized Substituted Fused Pyrazolo-, Triazolo- and Thiazolo-Pyrimidine Derivatives
por: Bahashwan, Saleh A., et al.
Publicado: (2014)

Lyophilization Preserves the Intrinsic Cardioprotective Activity of Bioinspired Cell-Derived Nanovesicles
por: Neupane, Yub Raj, et al.
Publicado: (2021)

The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?
por: Bassani, Davide, et al.
Publicado: (2022)

Preliminary Evidence of the Potent and Selective Adenosine A2B Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its Associated Metabolic Disorders in Mice
por: Kotańska, Magdalena, et al.
Publicado: (2022)

An overview of genetic services delivery for hereditary breast cancer
por: Reid, Sonya, et al.
Publicado: (2022)

Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus
por: Deng, Yong-Qiang, et al.
Publicado: (2016)

Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors
por: Jespers, Willem, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pmeq794u6ujt69lv5mhbitbe8t